When it comes down to the use of stem cells for treating interstitial lung diseases (ILD), we’re facing what appears to be an ethical dilemma. Treatments using certain types of stem cells have shown great promise in treating some non-lung related health issues, which has led us to reconsider how we can leverage this therapeutic potential for lung diseases and hopefully design safe protocols that won't allow the risks associated with treatments based on adult cells to be replicated in the case of lung disease therapy.
However, no long-term studies have been performed regarding the use of stem cell therapy in patients with pulmonary diseases if we specifically talk about lung diseases. Well, many people believe that these treatments could not only be ineffective but there's a chance they could cause increased patient death rates and make treatment options even less sustainable in the long term. On the other hand, some researchers believe that stem cell therapy for ILD can show us pretty promising results in the future. Stem cell therapy for lung fibrosis has also shown best result in improving lung functioning.
Furthermore, it is essential to remember that we can currently treat cardiopulmonary illnesses much more effectively than before through existing regenerative medicine procedures that do not involve transplanting new cells into the body. In the same way, researchers may find other cures for interstitial lung diseases. Nonetheless, if you want to get efficacious stem cell therapy for ILD in Mumbai at the most reasonable costs, you shall not look for any other option than Dr. Rajput’s Stem Cell Research Center.>